JP-listed companies
PhoenixBio Co.,Ltd.

PhoenixBio Co.,Ltd.JP:6190

Market cap

¥1.8B

P/E ratio

Income statement Balance sheet Cash flow

	Mar 31, 2015	Mar 31, 2016	Mar 31, 2017	Mar 31, 2018	Mar 31, 2019	Mar 31, 2020	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024
Net sales	881	1,217	1,229	902	1,228	1,311	1,014	1,325	2,124	1,715
Cost of sales	268	388	389	397	377	445	425	597	568	520
Beginning finished goods inventory	-	-	-	-	-	-	-	-	59	78
Cost of products manufactured	-	-	-	-	-	-	-	-	738	710
Total	-	-	-	-	-	-	-	-	797	788
Ending finished goods inventory	-	-	-	-	-	-	-	-	78	88
Cost of finished goods sold	-	-	-	-	-	-	-	-	720	700
Gross profit (loss)	613	829	840	506	851	866	588	728	1,556	1,195
Remuneration for directors (and other officers)	90	97	113	144	141	142	141	134	140	161
Salaries and allowances	80	109	116	130	206	215	207	209	264	311
Provision for bonuses	-	-	-	-	-	-	-	-	5	7
Retirement benefit expenses	2	3	5	6	6	6	7	8	10	18
Retirement benefit expenses	2	3	5	6	6	6	7	8	10	18
Depreciation	5	4	5	6	10	10	9	12	8	8
Depreciation	5	4	5	6	10	10	9	12	8	8
Research and development expenses	153	147	141	176	346	238	221	220	205	207
Research and development expenses	153	147	141	176	346	238	221	220	205	207
Commission expenses	100	126	111	98	112	106	79	80	104	133
Commission expenses	100	126	111	98	112	106	79	80	104	133
Other	133	152	208	215	343	295	201	232	312	339
Other	133	152	208	215	343	295	201	232	312	339
Selling, general and administrative expenses	563	638	698	774	1,163	1,013	865	895	1,048	1,184
Selling, general and administrative expenses	563	638	698	774	1,163	1,013	865	895	1,048	1,184
Operating profit (loss)	51	190	142	-269	-312	-147	-277	-168	508	11
Interest income	0	0	9	0	1	1	1	0	2	6
Foreign exchange gains	16	-	-	3	6	-	21	23	-	18
Subsidy income	-	-	3	0	24	31	16	10	9	16
Transportation income	-	-	-	-	-	-	-	5	4	2
Other	0	0	1	0	3	8	2	5	0	0
Non-operating income	16	0	14	4	34	40	54	41	15	42
Interest expenses	3	3	2	2	1	2	1	1	3	3
Share issuance costs	1	9	-	1	1	0	0	0	0	0
Foreign exchange losses	-	30	21	-	-	17	-	-	9	-
Provision of allowance for doubtful accounts	-	-	-	-	-	-	-	-	-	7
Non-operating expenses	4	41	23	2	2	18	1	1	12	10
Non-operating expenses	4	41	23	2	2	18	1	1	12	10
Ordinary profit (loss)	63	149	133	-267	-280	-125	-224	-128	511	44
Gain on redemption of investment securities	-	-	-	-	-	-	-	-	-	17
Gain on reversal of share acquisition rights	-	-	-	-	-	-	-	-	-	0
Extraordinary income	-	-	-	-	-	-	-	-	-	18
Loss on retirement of non-current assets	0	0	-	0	1	0	-	0	1	0
Impairment losses	-	-	-	-	15	292	-	265	-	1
Extraordinary losses	0	2	3	0	15	292	-	265	1	1
Extraordinary losses	0	2	3	0	15	292	-	265	1	1
Profit (loss) before income taxes	63	147	130	-267	-295	-418	-224	-393	511	60
Income taxes - current	6	22	7	2	3	2	3	3	50	9
Income taxes - deferred	-	-	-5	1	-0	-4	12	-8	-33	25
Income taxes	6	22	2	3	2	-2	14	-5	17	33
Profit (loss)	57	125	128	-271	-297	-416	-238	-388	493	26
Profit (loss) attributable to owners of parent	57	125	128	-271	-297	-416	-238	-388	493	26